Bill Text: IL HB0702 | 2013-2014 | 98th General Assembly | Amended

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Environmental Protection Act. Makes a technical change in a Section concerning the short title.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2013-08-16 - Public Act . . . . . . . . . 98-0366 [HB0702 Detail]

Download: Illinois-2013-HB0702-Amended.html

Sen. Terry Link

Filed: 5/3/2013

09800HB0702sam001LRB098 03526 JDS 44928 a
1
AMENDMENT TO HOUSE BILL 702
2 AMENDMENT NO. ______. Amend House Bill 702 by replacing
3everything after the enacting clause with the following:
4 "Section 5. The Environmental Protection Act is amended by
5changing Section 3.360 as follows:
6 (415 ILCS 5/3.360) (was 415 ILCS 5/3.84)
7 Sec. 3.360. Potentially infectious medical waste.
8 (a) "Potentially infectious medical waste" means the
9following types of waste generated in connection with the
10diagnosis, treatment (i.e., provision of medical services), or
11immunization of human beings or animals; research pertaining to
12the provision of medical services; or the production or testing
13of biologicals:
14 (1) Cultures and stocks. This waste shall include but
15 not be limited to cultures and stocks of agents infectious
16 to humans, and associated biologicals; cultures from

09800HB0702sam001- 2 -LRB098 03526 JDS 44928 a
1 medical or pathological laboratories; cultures and stocks
2 of infectious agents from research and industrial
3 laboratories; wastes from the production of biologicals;
4 discarded live or attenuated vaccines; or culture dishes
5 and devices used to transfer, inoculate, or mix cultures.
6 (2) Human pathological wastes. This waste shall
7 include tissue, organs, and body parts (except teeth and
8 the contiguous structures of bone and gum); body fluids
9 that are removed during surgery, autopsy, or other medical
10 procedures; or specimens of body fluids and their
11 containers.
12 (3) Human blood and blood products. This waste shall
13 include discarded human blood, blood components (e.g.,
14 serum and plasma), or saturated material containing free
15 flowing blood or blood components.
16 (4) Used sharps. This waste shall include but not be
17 limited to discarded sharps used in animal or human patient
18 care, medical research, or clinical or pharmaceutical
19 laboratories; hypodermic, intravenous, or other medical
20 needles; hypodermic or intravenous syringes; Pasteur
21 pipettes; scalpel blades; or blood vials. This waste shall
22 also include but not be limited to other types of broken or
23 unbroken glass (including slides and cover slips) in
24 contact with infectious agents.
25 (5) Animal waste. Animal waste means discarded
26 materials, including carcasses, body parts, body fluids,

09800HB0702sam001- 3 -LRB098 03526 JDS 44928 a
1 blood, or bedding originating from animals inoculated
2 during research, production of biologicals, or
3 pharmaceutical testing with agents infectious to humans.
4 (6) Isolation waste. This waste shall include
5 discarded materials contaminated with blood, excretions,
6 exudates, and secretions from humans that are isolated to
7 protect others from highly communicable diseases. "Highly
8 communicable diseases" means those diseases identified by
9 the Board in rules adopted under subsection (e) of Section
10 56.2 of this Act.
11 (7) Unused sharps. This waste shall include but not be
12 limited to the following unused, discarded sharps:
13 hypodermic, intravenous, or other needles; hypodermic or
14 intravenous syringes; or scalpel blades.
15 (b) Potentially infectious medical waste does not include:
16 (1) waste generated as general household waste;
17 (2) waste (except for sharps) for which the infectious
18 potential has been eliminated by treatment; or
19 (3) sharps that meet both of the following conditions:
20 (A) the infectious potential has been eliminated
21 from the sharps by treatment; and
22 (B) the sharps are rendered unrecognizable by
23 treatment; or .
24 (4) sharps that are managed in accordance with the
25 following requirements:
26 (A) the infectious potential is eliminated from

09800HB0702sam001- 4 -LRB098 03526 JDS 44928 a
1 the sharps by treatment at a facility that is permitted
2 by the Agency for the treatment of potentially
3 infectious medical waste;
4 (B) the sharps are certified by the treatment
5 facility as non-special waste in accordance with
6 Section 22.48 of this Act;
7 (C) the sharps are packaged at the treatment
8 facility the same as required under Board rules for
9 potentially infectious medical waste;
10 (D) the sharps are transported under the custody of
11 the treatment facility to a landfill permitted by the
12 Agency under Section 21 of this Act to accept municipal
13 waste for disposal; and
14 (E) the activities in subparagraphs (A) through
15 (D) of this paragraph (4) are authorized in, and
16 conducted in accordance with, a permit issued by the
17 Agency to the treatment facility.
18(Source: P.A. 92-574, eff. 6-26-02.)".
feedback